Navigation Links
Amgen introduces Autoinjector For Treating Anemia

Patients with chemotherapy-induced anemia and anemia associated with chronic kidney disease (CKD) will now have access to Amgen's Aranesp, //which is a prefilled autoinjector. The product will be available initially in the United States.

"With the availability of the Aranesp prefilled SureClick autoinjector, healthcare providers and patients now have a new secure and simple option that automatically delivers a complete subcutaneous injection in a single use," said Willard Dere, MD, senior vice president for global development and chief medical officer at Amgen. "The added safety features of the SureClick autoinjector minimize potential needlestick injuries, offering dependable benefits for nurses, oncologists and nephrologists who administer Aranesp in clinics and hospitals."

The Aranesp prefilled SureClick autoinjector has three important and unique safety features, including a safety cover that limits needle exposure before and after the subcutaneous injection, two audible clicks to announce the beginning and end of the injection, and a large inspection window that confirms it automatically delivered the complete injection. In a survey that included the use of the Aranesp prefilled SureClick autoinjector, most oncology nurses agreed that the device was easy to use.

The Centers for Disease Control and Prevention (CDC) estimates that one out of every seven healthcare professionals is accidentally stuck by a contaminated sharp, most often a needle, each year. Approximately 62 to 88 percent of needlestick injuries can potentially be prevented by the use of safer devices. To reduce these occupational hazards, the CDC has identified eight desirable characteristics for safety devices, and the Aranesp prefilled SureClick autoinjector has at least six of these characteristics.

The FDA approval of the Aranesp prefilled SureClick autoinjector broadens current administration options for healthcare providers and patients with anemia
'"/>




Page: 1 2 3 4

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. Treating eye pain eases migraine
3. Treating wounds without stitches
4. Treating varicose veins
5. Treating acne with laser
6. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
7. Treating Stroke Patients in Rural Areas
8. Free Tissue Transfer Effective in Treating Massive Skin Cancers
9. Treating Blocked Arteries In The Lower Limbs
10. Zinc Supplements Found To Be Effective In Treating Children With ADHD
11. Hormone Leptin Found To Be Effective In Treating Women With Infertility Problems
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...at in spite of depression being common among long-... treated//. "Stroke patients suffering from depre...ife and a higher rate of death, so it is important...stroke," study lead author Seana L. Paul, a resear...
...moderate asthma who were treated with anti-tumor n...nal antibody, experienced significantly// fewer di...ebo. This research appears in the first issue for ...f Respiratory and Critical Care Medicine, publishe...
...he big time killer AIDS/ HIV infection worldwide C...arheaded// by Dr Benigno Rodriguez M.D and his ext...ve presented their latest findings in the current ... Current therapeutic guidelines have been question...
... due to Japanese encephalitis, the death toll sinc...trict.// According to the Additional Director (He...ing illness have been reported from several parts ... Wednesday evening. Mr. Prasad said that 74 peopl...
Other Medicine News:Health News:Monoclonal Antibody Reduces Exacerbations in Asthmatics 2
(Date:9/4/2008)... SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstCa...y announced that the pivotal clinical study of,Pol...s partner, Chemische,Fabrik KREUSSLER & Co. GmbH (...point and has been submitted to FDA as part of a N...l clinical study, named the EASI (Efficacy and saf...
(Date:9/4/2008)... Pivotal Study Seeks to Enroll 750 Women at More T.... 4 /- QuatRx Pharmaceuticals, a,priv...velopment and,commercialization of compounds to tr...ers, today announced that it has initiated a secon... tablets), the company,s,estrogen-free oral therap...
(Date:9/4/2008)... Data Announcements Remain on Schedule with Two ... Clinical Data Release in November 2008, BRIDGEWA...ceuticals,Inc., a specialty pharmaceutical compan...etabolic disease, today announced the appointment ... of directors., Peter Garrambone,s career include...
(Date:9/3/2008)... - Long term follow up results from chronically...d exceed positive data obtained earlier in 2008, ...ificant and long-term antiviral effect of t...the way and strongly support move into a second ge...uvant IC31(R) acting through TLR ...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Batman Takes on Gotham City With a Little Help From Milk 20428 1Batman Takes on Gotham City With a Little Help From Milk 20428 2Texas Jury Awards 24250 Million Patent Infringement Verdict Against Boston Scientific in Balloon Catheter Lawsuit 20425 1Texas Jury Awards 24250 Million Patent Infringement Verdict Against Boston Scientific in Balloon Catheter Lawsuit 20425 2Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen New Survey Reveals 20422 1Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen New Survey Reveals 20422 2Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen New Survey Reveals 20422 3Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen New Survey Reveals 20422 4Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen New Survey Reveals 20422 5Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen New Survey Reveals 20422 6New Research and Treatment Options for Millions Suffering Headaches and Chronic Pain to be Presented at 10th Annual Headache and Pain Conference 20419 1New Research and Treatment Options for Millions Suffering Headaches and Chronic Pain to be Presented at 10th Annual Headache and Pain Conference 20419 2New Research and Treatment Options for Millions Suffering Headaches and Chronic Pain to be Presented at 10th Annual Headache and Pain Conference 20419 3
...ISING-WEIHENSTEPHAN, Germany, June 21, 2007 /PRNew...developing Anticalins(R), a,novel class of targete... its proprietary Duocalin(R) technology has succes...mmenting on this development, Dr Andreas Hohlbaum,...f Pieris said: "As Pieris,continues to validate th...
...NTAIN VIEW, Calif., June 22, 2007 /PRNewswire/ -- ...will present Phase 2,data from its Unit Dose Budes...ram at the World Asthma Meeting at the Lutfi Kirda...rkey. , The oral and poster presentation entitled,...e formulation of budesonide for,nebulized delivery...
Other Medicine Technology:Pieris Progresses Development of its Proprietary Biotherapeutics,Platform: Successful Demonstration of Dual Targeting With,Duocalin(R) Technology 2Pieris Progresses Development of its Proprietary Biotherapeutics,Platform: Successful Demonstration of Dual Targeting With,Duocalin(R) Technology 3MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2
...e DexCom STS Continuous Glucose Monitoring System ...elessly transmits blood glucose readings to the De...ludes a wirelike sensor which is inserted via the ...t under the skin where it is held in place by an a...
...rdioVault combines proven Eclipse,Plus or 850 EC...capability. Doctors,maintain all the benefits of...he,ability to view and access diagnostic-quality...iagnostic-quality viewing and printing,either f...
For practices performing routine Holter,monitoring, the Burdick Vision Holter,System with QuickStep Wizard provides a,practical, no-nonsense diagnostic tool ideal,for todays tightly managed h
For practices that need an advanced Holter,monitoring solution, the Burdick Vision,Premier Holter System provides a powerful,diagnostic tool. The Vision Premier system,adds expanded viewing c
Medicine Products: